In one paragraphArticle in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Vanja ZeremskiDepartment of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Sina A BeerDepartment of Hematology and Oncology, University Hospital Tuebingen, Tuebingen, Germany.ORCID 0009-0004-0609-2644 Frederik DammDepartment of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0001-5553-1173 Mareike FrickDepartment of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID 0000-0001-5216-0565 Tobias R HaageDepartment of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Stefan KnopDepartment of Hematology and Oncology, Nuremberg General Hospital and Paracelsus Medical School, Nuremberg, Germany.ORCID 0000-0003-1276-6639 Georg LenzMedical Department A for Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.
Markus MaulhardtDepartment for Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.ORCID 0009-0008-7585-8956 Susanne StriflerDepartment of Hematology and Oncology, Nuremberg General Hospital and Paracelsus Medical School, Nuremberg, Germany.
Evgenii ShumilovMedical Department A for Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany.ORCID 0000-0003-0178-1729 Stefan WirthsDepartment of Hematology and Oncology, University Hospital Tuebingen, Tuebingen, Germany.ORCID 0000-0003-2494-9862 Gerald WulfDepartment for Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.
Dimitrios MougiakakosDepartment of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany.ORCID 0000-0002-2817-6660 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42234948
PMCPMC13400874
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390